Highline Capital Management, L.P. Moderna, Inc. Transaction History

Highline Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$29.67 - $80.0 $7.42 Million - $20 Million	-250,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $1.78 Million - $3.16 Million	100,000 Added 66.67%	250,000 $7.49 Million
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $2.09 Million - $3.19 Million	150,000 New	150,000 $2.93 Million
Q2 2019 Aug 14, 2019	SELL	$13.7 - $28.34 $12.7 Million - $26.4 Million	-930,230 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$14.45 - $23.7 $8.49 Million - $13.9 Million	-587,712 Reduced 38.72%	930,230 $18.9 Million
Q4 2018 Feb 14, 2019	BUY	$13.52 - $18.8 $20.5 Million - $28.5 Million	1,517,942 New	1,517,942 $23.2 Million

928

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.2B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Highline Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Highline Capital Management, L.P. with notifications on news.